Kathleen A. Rickard Verona Pharma PLC (VRNA) insider trading activity
Kathleen A. Rickard is Chief Medical Officer of Verona Pharma plc. Currently has a direct ownership of 2.61 Million shares of VRNA, which is worth approximately $164 Million. The most recent transaction as insider was on Feb 01, 2023, when has been sold 89,960 shares (Ordinary Shares) at a price of $2.56 per share, resulting in proceeds of $230,297. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
2.61M
2.34%
3M change
4.49%
12M change
Total Value Held
$164 Million
Kathleen A. Rickard Transaction History
KAR
Kathleen A. Rickard
Chief Medical Officer
London, X0